@article{657f12dc47aa448998f1a0944753cdde,
title = "KDIGO 2022 CLINICAL PRACTICE GUIDELINE FOR DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE",
keywords = "angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, chronic kidney disease, dialysis, evidence-based, GLP-1 receptor agonist, glycemia, glycemic monitoring, glycemic targets, guideline, HbAlc, hemodialysis, KDIGO, lifestyle, metformin, models of care, nutrition, renin-angiotensin system, self-management, SGLT2 inhibitor, systematic review, teambased care",
author = "{de Boer}, {Ian H.} and Peter Rossing and Caramori, {M. Luiza} and Chan, {Juliana C. N.} and Heerspink, {Hiddo J. L.} and Clint Hurst and Kamlesh Khunti and Adrian Liew and Michos, {Erin D.} and Navaneethan, {Sankar D.} and Olowu, {Wasiu A.} and Tami Sadusky and Nikhil Tandon and Tuttle, {Katherine R.} and Christoph Wanner and Wilkens, {Katy G.} and Sophia Zoungas and Michel Jadoul and Winkelmayer, {Wolfgang C.} and Tonelli, {Marcello A.} and Craig, {Jonathan C.} and Strippoli, {Giovanni F. M.} and Tunnicliffe, {David J.} and Higgins, {Gail Y.} and Patrizia Natale and Cooper, {Tess E.} and Willis, {Narelle S.} and {KDIGO Diabetes Work Group}",
year = "2022",
month = nov,
doi = "10.1016/j.kint.2022.06.008",
language = "English",
volume = "102",
pages = "S1--S127",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Elsevier BV",
number = "5",
}